Vitamin D3 analogs
US6452028B1 · kind B1 · utility
3Cited by
4References
9Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 25, 2000 |
| Grant date | Sep 17, 2002 |
| Priority date | — |
| Expiry date | Aug 25, 2020 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/59
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A compound of the formula wherein R is hydrogen or hydroxy, each R1 is ethyl, propyl, butyl, isopropyl or t-butyl, X is ═CH2, or when R is hydroxy, X is hydrogen or ═CH2,and A is —C≡C—, or—CH2—CH2—.These compounds are useful for the treatment of hyperproliferative disorders, skin diseases, and sebaceous gland diseases.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.